AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparison of the Effectiveness of Ultrasound-guided Techniques and Infrared Illumination, Compared With the Standard Approach to Peripheral Venous Line Placement in People With Difficult Venous Access

RecruitingNAAges 18 Years - anyAllPoitiers University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Peripheral venous catheterization (PVC) is the most common invasive procedure in healthcare worldwide. Improving the success rate of PVC on the first attempt is crucial for patients, as it impacts pain, anxiety, the risk of extravasation, rapid access to care, and the patient-provider relationship. For healthcare providers, a higher success rate enhances self-confidence and autonomy, while institutions benefit from improved reputation and reduced costs. In the Poitiers hosptial, one in ten catheters is used in imaging services, with CT scan departments accounting for 66.3% of catheter usage due to iodinated contrast injections. Literature suggests two techniques to enhance PVC success: ultrasound-guided and infrared illumination methods. These techniques appear effective primarily for patients with difficult venous access. Additionally, the A-DIVA clinical score has been developed to pr

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients aged 18 or over * Patient with a CT scan appointment and a medical prescription requiring a peripheral venous line. * Patient with an A-DIVA score greater than or equal to 2. * Patient able and willing to comply with all study procedures. * Patient covered by a social security scheme or covered through a third party. * Patients who have given their free and informed written consent following clear and fair information about the study. Exclusion Criteria: * Patient with a contraindication to VVP insertion: * Arm with arteriovenous fistula * Limb with an orthopaedic or vascular prosthesis * Previous mastectomy, axillary lymph node dissection or homolateral radiotherapy of the arm * Paralysed limb * Presence of haematomas or puncture site wounds * Limb with phlebitis or infection * Patients already included in the study * Persons benefiting from enhanced protection, i.e. minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment, pregnant or breast-feeding women, adults under legal protection and patients in emergency situations.
๐Ÿ’Š

What it tests

  • Infrared peripheral venous technique
  • Ultrasound-guided peripheral venous technique
  • Landmark technique
๐Ÿ“

Where

1 site
Poitiers Hospital
Poitiers, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy